Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
June 13, 2022
The new name Hemolens Diagnostics fully reflects the direction in which our company is evolving, bringing together critical elements of technology.
Over the past 7 years, we have successfully implemented a number of strategic projects to create a unique technology for the non-invasive diagnosis of coronary heart disease, which will soon revolutionize the world of medicine and be available to Polish patients.
The first part of the name ‘Hemo’ comes from the word hemodynamics, which is a branch of medicine that deals with the dynamics of blood flow. Lens’, on the other hand, emphasizes the company’s focus on diagnostics based on computer-assisted fluid flow analysis, which we develop and deliver to patients in Poland and Europe.